MedTrace Logo

Thunder Trial - Local Taxan With Short Time Contact for Reduction of Restenosis in Distal Arteries

NCT00156624 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2006-04-25

No results posted yet for this study

Summary

The Thunder Trail is a randomized , double-blinded, placebo controlled German multi-centre study on the efficacy of local paclitaxel for prevention of restenosis in the superficial and popliteal artery.

Conditions

  • Arterial Occlusive Diseases

Interventions

DRUG

Balloon Angioplasty with or without drug administration

Sponsors & Collaborators

  • Herzzentrum Bad Krotzingen

    collaborator UNKNOWN

  • Humboldt-Universität zu Berlin

    collaborator OTHER

  • University of Greifswald

    collaborator OTHER

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Gunnar Tepe, MD · University Hospital of Tuebingen

  • Gunnar Tepe, MD · University Hospital Tuebingen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Completion
2007-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00156624 on ClinicalTrials.gov